NCT02278575View on ClinicalTrials.gov

Atenativ Effect on Uterine Blood Flow and Preeclampsia

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions

Antithrombin III Deficiency

Interventions

DRUG

Atenativ

intravenous transfusion

Trial Locations (1)

41685

Dept Obstetrics, Sahlgrenska University Hospital, Gothenburg

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Octapharma

INDUSTRY

lead

Vastra Gotaland Region

OTHER_GOV